The Journal of Case Reports and Series is an open-access journal dedicated to only case reports and series. The journal caters to wide aspects dealing with ethics, policies, biomechanics, innovations and biotechnology related with all medical and surgical fields. Articles related with engineering aspects and physiotherapy-occupational therapy shall also be encouraged.
As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
The submission has not been previously published, nor is it before another journal for consideration (or an explanation has been provided in Comments to the Editor).
The submission file is in OpenOffice, Microsoft Word, or RTF document file format.
Where available, URLs for the references have been provided.
The text is single-spaced; uses a 12-point font; employs italics, rather than underlining (except with URL addresses); and all illustrations, figures, and tables are placed within the text at the appropriate points, rather than at the end.
The text adheres to the stylistic and bibliographic requirements outlined in the Author Guidelines.
ACCEPTED MANUSCRIPT TYPES
The JCRS only accepts FOUR article types. To be considered for publication, each article type must include the following sections.
Case Report with Literature Review article
Introduction & Background
Editorial & Letter to Editor
CORRESPONDING AUTHOR RESPONSIBILITIES
Articles should be submitted by the author. The listed article submitter will be considered the submitting and corresponding author, and will assume all responsibility throughout the article’s peer review and publication. JMRI does not distinguish between submitting and corresponding authors in order to keep this process simple and efficient.
Submitting on behalf of an author: If an administrator wishes to submit an article on behalf of an author, the administrator must do so while signed in with the author’s JMRI account. Additionally, all JMRI email notifications sent during the submission process will be sent to the submitting author (not the administrator). For these reasons, we strongly recommend that authors submit their own work.
Naming Order for Contributors
The order of naming the contributors should be based on the relative contribution of the contributor towards the study and the writing of the manuscript. Once submitted, the order cannot be changed without the written consent of all the contributors.
No addition of author(s) will be entertained post submission. Exception to this will be made only with proper justification supported by institution/university head.
Number of Contributors
In the event of a study carried out in a single institute, the number of contributors should not exceed eight. For case-reports, images, letters to the editor, and review articles, the number of contributors should not exceed five. There should be a written justification if the number of contributors exceeds five. If the JMRI feels necessary it may ask for description of the contribution of authors towards the manuscript.
Title page- In separate lines, title page should contain the title of the manuscript, the name(s) and affiliation(s) of the author(s), and the mailing address, telephone and fax numbers, and e-mail address of the corresponding author. The title must be specific, concise and informative.
Title - EVALUATION OF -----------(12 FONT SIZE, TIMES NEW ROMAN, NORMAL, BOLD) - IN UPPERCASE ONLY Authors - Aneesh K, Laxmi Kumar ---(12 FONT SIZE, TIMES NEW ROMAN, NORMAL, BOLD) - IN UPPERCASE ONLY
Keywords and abstract- Please include 3-10 keywords for indexing purposes; Full-length manuscript submission should contain an abstract of up to 250 words in a structured form, consisting of: Objective, Methods, Results, and Conclusion.
Headings – INTRODUCTION, MATERIALS AND METHODS, RESULTS, DISCUSSION, CONCLUSION
Subheadings- Preparation of extracts
Introduction- It should summarize the rationale, provides a concise research background (not an exhaustive review) and states in single sentence the objective of the study. Please do not include any results or the conclusion of the study.
Materials and methods- All the ethical permission associated in the research work must be specified. It should provide technical information about the study. Published methodological details are not needed to describe that have been published previously. Specifications (including the manufacturer, city, and the country) should be given for the main drugs, chemicals, and instruments. Indicate the statistical methods used and identify statistical significance using superscripts (* and **) following the data (*P < 0.05, **P < 0.01).
Results- It should reveal the findings of works.
Discussion- It should be with the interpretation of the results and their comparison with those of other studies. No need to repeat the results, review literature, textbook knowledge or cite references that do not have a close relationship with the present result.
Conclusion – conclude the study linking back to the aim of the study.
Abbreviations- At the first appearance in the abstract and the text, abbreviations should be preceded by words for which they stand.
Tables- Tables must be concise and cited consecutively using Arabic numerals in the text (table 1, table 2...etc.). The title of the table should clearly indicate the nature of the contents and sufficient detail should be included in the footnote to facilitate interpretation without reference to the text. Use horizontal rules only.
Table Format – It should be designed using table tools of MS Word.
Figures -Figures (photographs, drawings, diagrams and charts) should be clear, easily legible and cited consecutively using Arabic numerals in the text(fig. 1, fig. 2...etc.). Please supply figures 1.5 to 2 times the size at which they will be finally reproduced. For line work, submit black-ink drawings of professional quality. Micrographs or other glossy photographs must be of the highest quality. Use standard symbols: ○, ●, ×, □, ■, △, ▲. Freehand or typewritten lettering is unacceptable. If a figure comprises more than one glossy photograph, these should be marked A, B, C...etc. Figure legends should be marked clearly with their correspond letters. Legends should contain sufficient detail to permit figure interpretation without reference to the text. Scale markers should be indicated in the photographs. Color plates are also welcome. The choice of cover art illustration will be made by the Editor.
Manuscripts that fail to confirm to the requirements of the Journal, as specified under 'Instructions to Authors', will be rejected outright.
Tables and figures should be cited in the text in numerical order. Table 2 should not be first cited before Table 1.
JCRS uses a modified Vancouver Style. You may also download End Note Style for JMRI from HERE and use it for citing the references.
Otherwise, Please note: ARTICLES SHOULD BE FOLLOWED EITHER BY DOI OR URL AS SHOWN BELOW. KINDLY DO ADD PMID LINK AS WELL, IF IT IS AVAILABLE.
Articles in Journals
Mehta V, Agarwal S. Does Vitamin D Deficiency Lead to Hypertension?. Cureus. 2017;9(2):e1038. PMID: https://www.ncbi.nlm.nih.gov/pubmed/28357170. DOI: https://doi.org/10.7759/cureus.1038.
Mehta V, Pusukuru R, Ghodke B. Association of Thyroid Stimulating Hormone and Lipid Profile in Pregnancy. Journal Of Medical Research And Innovation. 2017;1(2):AU1-AU6. URI: http://jmri.org.in/index.php/jmri/article/view/50.
Books and Other Monographs
Personal author(s): Ringsven MK, Bond D. Gerontology and leadership skills for nurses. 2nd ed. Albany (NY): Delmar Publishers;1996.
Editor(s), compiler(s) as author: Norman IJ, Redfern SJ, editors. Mental health care for elderly people. New York: Churchill Livingstone;1996.
Chapter in a book: Phillips SJ, Whisnant JP. Hypertension and stroke. In: Laragh JH, Brenner BM, editors. Hypertension: pathophysiology, diagnosis, and management. 2nd ed. New York: Raven Press; 1995. p. 465-78.
References should be numbered consecutively in the order in which they are first mentioned in the text (not in alphabetic order). Identify references in text, tables, and legends by Arabic numerals in parenthesis/bracket like- . References cited only in tables or figure legends should be numbered in accordance with the sequence established by the first identification in the text of the particular table or figure. Use the style of the examples below. Use complete name of the journal for non-indexed journals. Avoid using abstracts as references. Information from manuscripts submitted but not accepted should be cited in the text as “unpublished observations” with written permission from the source. Avoid citing a “personal communication” unless it provides essential information not available from a public source, in which case the name of the person and date of communication should be cited in parentheses in the text. For scientific articles, contributors should obtain written permission and confirmation of accuracy from the source of a personal communication.
The commonly cited types of references are shown here, for other types of references such as electronic media, newspaper items, etc. please refer to ICMJE Guidelines (http://www.icmje.org).
The journal publishes exciting findings, preliminary data or studies that did not yield enough information to make a full paper as short communications. These have the same format requirements as full papers but are only up to 5 pages in length. Short Communications should not have subtitles such as Introduction, Materials and Methods, Results and Discussion - all these have to be merged into the running text. Short Communications preferably should have only 3-4 illustrations.
It should be divided in Title page, Abstract (non structured), Keywords, Introduction, Case Report, Discussion, Conclusion, Acknowledgement, References.
Should be about 18 pages long, contain up-to-date information, comprehensively cover relevant literature and preferably be written by scientists who have in-depth knowledge on the topic. All format requirements are same as those applicable to full papers. Review articles need not be divided into sections such as Materials and Methods and Results and Discussion, but should definitely have an Abstract and Introduction, if necessary.
Conflict of Interest statement
It must be declared by authors.
Contribution of each author should be given in the manuscript immediate after acknowledgment/conclusion.
Copyrights: Author holds the copyright post publication in case of open access. The publisher holds the rights in case of subscription based articles.
Publication Fees for Authors:
IF FAST-TRACK Service is Required
Fast-track publication service is provided to shorten the time to decision and publication. The entire peer review can be done within 2-3 weeks and the article shall be published within 2-3 days post acceptance as Article in Press.
If you wish to use fast-track publication service, please submit your manuscript and write to the editor with manuscript ID and journal's name at email@example.com.
The charge for fast track service is 6000 INR + 18% GST (for Indian author) or 150 USD (for foreign authors). All articles published through this service shall be made open access as complimentary.
The charge has to be paid with submission of the article. If the article is not accepted, the entire amount shall be refunded.
For hosting the conference proceedings
299 $ for conferences that shall take place in any country other India,
10,000 INR for conferences that shall take place in India.
Editorial Policies JCRS expect the highest ethical standards from their authors, reviewers and editors while conducting research, submitting papers and throughout the peer-review process. JMRI follows double-blind peer review process.
Redundant or duplicate publication A publication that overlaps or relates substantially with any article that is already published, in press, or under consideration/submission it is considered as Duplicate or redundant publication. (International Committee of the Medical Editors http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/overlapping-publications.html).
Duplicate or redundant submission is identical manuscript (or having the similar data) that is submitted to various journals at the same time. International copyright laws, ethical conducts, and cost effective use of resourceensure originality of the manuscript submitted. (International Council of the Medical Editors. http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/overlapping-publications.html)
Material submitted must be original and should not have published or submitted elsewhere while under consideration for publication. According to the APA code of ethics (APA Publication Manual, 2010) duplicate publication is violation and will lead to prompt rejection of the submitted manuscript.
In case of any doubts, author should seek advice from the editorial board member in handling their manuscript. If author is re-using a figure published elsewhere or that has been copyrighted then the author must get prior approval from the previous publisher or the copyright holder for the figure to be re-published. In case, author is unaware of the copyright issues and the material has been published, the author must submit a duplicate material for submission by acknowledging the source of the information, so that the ethical violation can be corrected.
Conflicts of interest In order to maintain transparency and help readers to form their own judgements of potential bias, authors should declare any competing financial interests related to the work that has been described or presented.
During the submission, every author should reveal the financial interests or collaborations if any, that may raise conflict or bias directly or indirectly in the submitted work including conclusions, opinions given or implications, or any other sources of funding for related direct or indirect academic competition.
However, in case of manuscript acceptance, the information related to Conflict of Interest should be mentioned in a published statement.
Permissions to reproduce previously published material Permission is essential to reproduce material from the copyright holder. Articles cannot be directly published without these permissions.
For authors who submit the article and vanishes
Authors, when disappear after submitting the article, the journal holds the right to either publish or not. Sometimes the journal will publish the article and will only retract if the authors sends an appology letter to the journal for wasting its time. Instead of vanishing, please send us a mail, that you do not wish to publish in the journal, it will save our time and resources. We will try to mail the authors multiple times before acknowledging the fact that the author has vanished. If we receive an apology post-publication, we would retract the paper. This even applies to the back dated papers and even those who has been sent a rejection mail due to no reply from authors.
Withdrawal of articles The journal is vowed to ensure the originality and authenticity of all articles published in it. In cases where the editorial team observes any technical or ethical discrepancy in an article viz. multiple submissions of the data, plagiarism, deceitful manipulation of data, spurious authorship claims, it may be withdrawn. The option of withdrawal mainly pertains to the articles that are currently in Press. Such articles are yet to be published formally and thus lack volume/issue/page information. Immediately after the article is withdrawn, the entire content of the article is removed from the journal website and a withdrawal notice is placed instead.
Retraction of published articles Articles published in the journal may be retracted by the author(s), University or institute the authors are affiliated to, funding agency of the publishedwork, editor-in-chief or publisher; if any ethical infringement or data manipulation is observed or notified by third party. Other situations that may lead to retraction of published articles include duplicate submissions, presentation of falsified data, unscrupulous authorship claims and detection of plagiarism.
Before retracting any of the published articles, the journal confers with the respective author(s) regarding the same. A retraction note duly signed by the author(s) and/or editor(s) is published in the paginated part of the subsequent issue of the journal.
Patient consent forms It is very essential to protect the patient’s right to privacy. Kindly collect and preserve copies of patient’s consent forms that mention patient’s or’ your experiment details clearly, including the grant permission for the publication of photographs or any other material that may recognise them. Yet, if the consent form did not comprise these details it is essential to obtain it or remove the identified material from the document. However, the obtained statement must be included in the ‘Methods’ section of your manuscript. If required, the Editors may request a copy of any consent form.
Ethics committee approval All the manuscripts dealing with the original human or animal data should include a statement on ethics approval at the commencement of the Methods section. It should information on the name and the address of the responsible ethics committee, the protocol number, along with the date of approval that is attributed by the ethics committee. For the studies carried on human participants, it is necessary to state evidently that you obtained the written and informed consent from the participants involved. Kindly, refer the latest version of the Declaration of Helsinki for this purpose. Similarly, experiments that involve animals must provide the state of animal care and licensing guidelines under which the study was performed and is reported.This should be provided inaccordance with the ARRIVE statement(Animals in Research: Reporting In Vivo Experiments). In any case, if ethics clearance was not obligatory or if there was any deviation or change from the standard of ethical requests, it is required to state the specified reason. Please note that the editors might ask you to provide evidence of ethical approval. Besides, If you have approval from a National Drug Agency (or similar), please state it by providing details. This can be particularly useful when discussing the use of unlicensed drugs.